Q Med Abseminariegatan 21uppsala Se 75 752 Pma Numberp040024 Supplement Numbers136 Date Received11 21 2022 Decision Date12 23 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Q Med Abseminariegatan 21uppsala Se 75 752 Pma Numberp040024 Supplement Numbers136 Date Received11 21 2022 Decision Date12 23 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P040024S136 Q-Med ABseminariegatan 21uppsala SE-75-752- PMA NumberP040024 Supplement NumberS136 Date Received11/21/2022 Decision Date12/23/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No	Restylane® Silk Injectable Gel	2022-12-23